257 related articles for article (PubMed ID: 17881234)
1. Novel analogs of D-e-MAPP and B13. Part 2: signature effects on bioactive sphingolipids.
Bielawska A; Bielawski J; Szulc ZM; Mayroo N; Liu X; Bai A; Elojeimy S; Rembiesa B; Pierce J; Norris JS; Hannun YA
Bioorg Med Chem; 2008 Jan; 16(2):1032-45. PubMed ID: 17881234
[TBL] [Abstract][Full Text] [Related]
2. Novel analogs of D-e-MAPP and B13. Part 1: synthesis and evaluation as potential anticancer agents.
Szulc ZM; Mayroo N; Bai A; Bielawski J; Liu X; Norris JS; Hannun YA; Bielawska A
Bioorg Med Chem; 2008 Jan; 16(2):1015-31. PubMed ID: 17869115
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of erythro- B13 enantiomers and stereospecific action of full set of B13-isomers in MCF7 breast carcinoma cells: Cellular metabolism and effects on sphingolipids.
Bai A; Bielawski J; Bielawska A; Hannun YA
Bioorg Med Chem; 2021 Feb; 32():116011. PubMed ID: 33461145
[TBL] [Abstract][Full Text] [Related]
4. (1S,2R)-D-erythro-2-(N-myristoylamino)-1-phenyl-1-propanol as an inhibitor of ceramidase.
Bielawska A; Greenberg MS; Perry D; Jayadev S; Shayman JA; McKay C; Hannun YA
J Biol Chem; 1996 May; 271(21):12646-54. PubMed ID: 8647877
[TBL] [Abstract][Full Text] [Related]
5. Effect of N-acetylsphingosine (C2) and the ceramidase inhibitor (1S,2R)-D-erythro-2-(N-myristoylamino)-1-phenyl-1-propanol on the regulation of Sertoli cell function.
Meroni SB; Cánepa DF; Pellizzari EH; Schteingart HF; Cigorraga SB
J Androl; 1999; 20(5):619-25. PubMed ID: 10520574
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and bioevaluation of omega-N-amino analogs of B13.
Bai A; Szulc ZM; Bielawski J; Mayroo N; Liu X; Norris J; Hannun YA; Bielawska A
Bioorg Med Chem; 2009 Mar; 17(5):1840-8. PubMed ID: 19217788
[TBL] [Abstract][Full Text] [Related]
7. Structural requirements of ceramide and sphingosine based inhibitors of mitochondrial ceramidase.
Usta J; El Bawab S; Roddy P; Szulc ZM; Yusuf ; Hannun A; Bielawska A
Biochemistry; 2001 Aug; 40(32):9657-68. PubMed ID: 11583166
[TBL] [Abstract][Full Text] [Related]
8. Bcl-2 overexpression prevents apoptosis induced by ceramidase inhibitors in malignant melanoma and HaCaT keratinocytes.
Raisova M; Goltz G; Bektas M; Bielawska A; Riebeling C; Hossini AM; Eberle J; Hannun YA; Orfanos CE; Geilen CC
FEBS Lett; 2002 Apr; 516(1-3):47-52. PubMed ID: 11959101
[TBL] [Abstract][Full Text] [Related]
9. Induction of apoptotic cell death and prevention of tumor growth by ceramide analogues in metastatic human colon cancer.
Selzner M; Bielawska A; Morse MA; Rüdiger HA; Sindram D; Hannun YA; Clavien PA
Cancer Res; 2001 Feb; 61(3):1233-40. PubMed ID: 11221856
[TBL] [Abstract][Full Text] [Related]
10. Neutral ceramidase gene: role in regulating ceramide-induced apoptosis.
Choi MS; Anderson MA; Zhang Z; Zimonjic DB; Popescu N; Mukherjee AB
Gene; 2003 Oct; 315():113-22. PubMed ID: 14557071
[TBL] [Abstract][Full Text] [Related]
11. Probing compartment-specific sphingolipids with targeted bacterial sphingomyelinases and ceramidases.
Sakamoto W; Canals D; Salamone S; Allopenna J; Clarke CJ; Snider J; Obeid LM; Hannun YA
J Lipid Res; 2019 Nov; 60(11):1841-1850. PubMed ID: 31243119
[TBL] [Abstract][Full Text] [Related]
12. Novel agents targeting bioactive sphingolipids for the treatment of cancer.
Adan-Gokbulut A; Kartal-Yandim M; Iskender G; Baran Y
Curr Med Chem; 2013; 20(1):108-22. PubMed ID: 23244584
[TBL] [Abstract][Full Text] [Related]
13. Ceramide conversion to sphingosine-1-phosphate is essential for survival in C3H10T1/2 cells.
Castillo SS; Teegarden D
J Nutr; 2001 Nov; 131(11):2826-30. PubMed ID: 11694603
[TBL] [Abstract][Full Text] [Related]
14. Tailoring structure-function and targeting properties of ceramides by site-specific cationization.
Szulc ZM; Bielawski J; Gracz H; Gustilo M; Mayroo N; Hannun YA; Obeid LM; Bielawska A
Bioorg Med Chem; 2006 Nov; 14(21):7083-104. PubMed ID: 16919460
[TBL] [Abstract][Full Text] [Related]
15. Role of alkaline ceramidases in the generation of sphingosine and its phosphate in erythrocytes.
Xu R; Sun W; Jin J; Obeid LM; Mao C
FASEB J; 2010 Jul; 24(7):2507-15. PubMed ID: 20207939
[TBL] [Abstract][Full Text] [Related]
16. Ceramidases: regulators of cellular responses mediated by ceramide, sphingosine, and sphingosine-1-phosphate.
Mao C; Obeid LM
Biochim Biophys Acta; 2008 Sep; 1781(9):424-34. PubMed ID: 18619555
[TBL] [Abstract][Full Text] [Related]
17. Neutral ceramidase encoded by the Asah2 gene is essential for the intestinal degradation of sphingolipids.
Kono M; Dreier JL; Ellis JM; Allende ML; Kalkofen DN; Sanders KM; Bielawski J; Bielawska A; Hannun YA; Proia RL
J Biol Chem; 2006 Mar; 281(11):7324-31. PubMed ID: 16380386
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of sphingosine and sphingosine 1-phosphate generation in human platelets.
Tani M; Sano T; Ito M; Igarashi Y
J Lipid Res; 2005 Nov; 46(11):2458-67. PubMed ID: 16061940
[TBL] [Abstract][Full Text] [Related]
19. Targeting (cellular) lysosomal acid ceramidase by B13: design, synthesis and evaluation of novel DMG-B13 ester prodrugs.
Bai A; Szulc ZM; Bielawski J; Pierce JS; Rembiesa B; Terzieva S; Mao C; Xu R; Wu B; Clarke CJ; Newcomb B; Liu X; Norris J; Hannun YA; Bielawska A
Bioorg Med Chem; 2014 Dec; 22(24):6933-44. PubMed ID: 25456083
[TBL] [Abstract][Full Text] [Related]
20. Blood sphingolipidomics in healthy humans: impact of sample collection methodology.
Hammad SM; Pierce JS; Soodavar F; Smith KJ; Al Gadban MM; Rembiesa B; Klein RL; Hannun YA; Bielawski J; Bielawska A
J Lipid Res; 2010 Oct; 51(10):3074-87. PubMed ID: 20660127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
